IMMUNITYBIO AND RAFA ANNOUNCE ISRAELI MINISTRY OF HEALTH APPROVAL OF ANKTIVA® PLUS BCG FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU

Reuters · 6d ago

Please log in to view news